Financial Advocates Investment Management Mannkind Corp Transaction History

Financial Advocates Investment Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.79 - $4.04 $18,437 - $41,612	-10,300 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$0.84 - $1.76 $8,652 - $18,128	10,300 New	10,300 $11,000
Q4 2019 Feb 13, 2020	SELL	$1.14 - $1.49 $22,343 - $29,204	-19,600 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$1.14 - $2.25 $11,399 - $22,500	10,000 Added 104.17%	19,600 $39,000
Q4 2018 Feb 14, 2019	SELL	$1.02 - $2.05 $3,020 - $6,070	-2,961 Reduced 23.57%	9,600 $10,000
Q2 2018 Aug 09, 2018	BUY	$1.59 - $2.38 $1,272 - $1,904	800 Added 6.8%	12,561 $24,000
Q1 2018 May 11, 2018	BUY	$2.28 - $3.8 $26,815 - $44,691	11,761 New	11,761 $27,000

248

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.44B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.